GO
Loading...

Biogen Idec Inc

More

  • Midday Glance: Biotechnology companies Thursday, 24 Jul 2014 | 1:23 PM ET

    Biogen Idec fell$. 94 or. 3 percent, to $336.66. Celgene Corp. fell $3.22 or 3.6 percent, to $85.90. Gilead Sciences Inc. rose$. 04 or percent, to $90.38.

  • July 24- Celgene Corp reported a 25 percent rise in second-quarter profit, edging out Wall Street expectations, but a raised 2014 forecast failed to excite investors and its shares fell nearly 4 percent.

  • Early Glance: Biotechnology companies Thursday, 24 Jul 2014 | 11:37 AM ET

    Amgen Inc. fell$. 51 or. 4 percent, to $121.50. Biogen Idec rose$. 29 or. 1 percent, to $337.89. Celgene Corp. fell $3.63 or 4.1 percent, to $85.49.

  • *Apple rallies after results, boosting tech names. NEW YORK, July 23- U.S. stocks ended mostly higher on Wednesday, with the S&P 500 closing at a record on Apple's bullish results, though Boeing weighed on the Dow and conflicts in Ukraine and the Gaza Strip kept the broader market's gains in check.

  • Delta and Apple are big market movers Wednesday, 23 Jul 2014 | 4:38 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:. Delta Air Lines Inc., up $1.47 to $39.15. GlaxoSmithKline Plc., down $3.18 to $50.04.

  • U.S. sales of $585 million far exceeded Wall Street forecasts in the $485 million range. The drug is taking flight as patients with the progressive neurological disease move from injectable treatments to more convenient pills, including Novartis AG's Gilenya and Sanofi SA's Aubagio.

  • *Apple rallies after results, boosting tech names. NEW YORK, July 23- U.S. stocks were largely higher on Wednesday, with the S&P 500 hitting another record high after bullish results from tech giants Apple and Microsoft, though technical resistance and conflicts in Ukraine and the Gaza Strip kept gains in check.

  • *Microsoft sees end to Nokia losses, shares rise. NEW YORK, July 23- The S&P 500 hit a record high on Wednesday, lifted by bullish earnings from companies like Apple and Microsoft, though technical resistance and conflicts in Ukraine and the Gaza Strip kept gains in check.

  • S&P 500 ekes out record high as earnings roll in Wednesday, 23 Jul 2014 | 9:06 AM ET

    NEW YORK— The stock market eked out a record high Wednesday, as investors weighed positive earnings from the technology industry against disappointing news from Boeing and other companies. Microsoft also announced results that beat forecasts.

  • *Microsoft sees end to Nokia losses, shares rise. NEW YORK, July 23- U.S. stocks were set to rise slightly at the open on Wednesday, boosted by bullish earnings from companies like Boeing, Pepsi and Microsoft, though conflicts in Ukraine and the Gaza Strip weighed on investor confidence.

  • *Microsoft sees end to Nokia losses, shares rise. NEW YORK, July 23- U.S. stock index futures edged up on Wednesday, boosted by bullish earnings from companies like Microsoft and Boeing, though conflicts in Ukraine and the Gaza Strip weighed on investor confidence.

  • July 23- Biogen Idec Inc reported sharply higher-than-expected quarterly revenue on surging sales of its new Tecfidera treatment for multiple sclerosis, and the company raised its full-year profit forecast. U.S. sales of $585 million blew past Wall Street expectations in the $485 million range.

  • Biogen revenue trounces forecast as MS drug sales surge Wednesday, 23 Jul 2014 | 7:04 AM ET

    July 23- Biogen Idec Inc reported sharply higher-than-expected quarterly revenue on surging sales of its new Tecfidera oral treatment for multiple sclerosis, and the company raised its full-year profit forecast. The company on Wednesday said it had earned $723.1 million, or $3.01 per share, in the second quarter.

  • Final Glance: Biotechnology companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Amgen Inc. rose $2.08 or 1.7 percent, to $121.11. Biogen Idec rose $1.17 or. 4 percent, to $303.67. Celgene Corp. rose $1.35 or 1.6 percent, to $86.66.

  • Midday Glance: Biotechnology companies Tuesday, 22 Jul 2014 | 1:57 PM ET

    Amgen Inc. rose $1.68 or 1.4 percent, to $120.71. Biogen Idec rose $2.64 or. 9 percent, to $305.14. Celgene Corp. rose $1.30 or 1.5 percent, to $86.61.

  • Early Glance: Biotechnology companies Tuesday, 22 Jul 2014 | 11:16 AM ET

    Amgen Inc. rose $1.30 or 1.1 percent, to $120.33. Biogen Idec rose $5.25 or 1.7 percent, to $307.75. Celgene Corp. rose $1.69 or 2.0 percent, to $87.00.

  • UPDATE 2-Gambro acquisition boosts Baxter's sales Thursday, 17 Jul 2014 | 1:30 PM ET

    July 17- Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly adjusted earnings, driven primarily by a surge in sales of the dialysis products it gained from its acquisition of Gambro AB last year.

  • Midday Glance: Biotechnology companies Wednesday, 16 Jul 2014 | 2:54 PM ET

    Amgen Inc. rose$. 05 or percent, to $116.91. Biogen Idec fell $6.64 or 2.1 percent, to $305.36. Celgene Corp. fell$. 70 or. 8 percent, to $86.08.

  • Early Glance: Biotechnology companies Wednesday, 16 Jul 2014 | 11:11 AM ET

    Amgen Inc. rose$. 29 or. 3 percent, to $117.16. Biogen Idec fell $4.28 or 1.4 percent, to $307.72. Celgene Corp. rose$. 21 or. 2 percent, to $86.99.

  • Midday Glance: Biotechnology companies Monday, 14 Jul 2014 | 1:29 PM ET

    Amgen Inc. fell$. 54 or. 5 percent, to $119.23. Biogen Idec fell $2.91 or. 9 percent, to $319.31. Celgene Corp. fell $1.01 or 1.1 percent, to $88.18.